AYUSHEXCIL, Zepto sign MoU to improve access and quality assurance for Ayush products

The recent Memorandum of Understanding (MoU) between the Ayush Export Promotion Council (AYUSHEXCIL) and the e-commerce platform Zepto marks a significant step in the ongoing efforts to integrate traditional Indian medicine systems with modern retail and global markets. This collaboration, highlighted by Union Ayush Minister Prataprao Jadhav, underscores the government's commitment to leveraging innovation-driven Indian startups to improve last-mile access and quality assurance for Ayush products across the country. **Background Context and What Happened:** India boasts a rich heritage of traditional medicine systems, collectively known as AYUSH – Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa-Rigpa, and Homoeopathy. Historically, these systems, despite their deep roots and efficacy, faced challenges in terms of standardization, quality control, market access, and public perception compared to allopathic medicine. To address this, the Government of India established the Ministry of Ayush in 2014, signaling a strong policy push to promote, regulate, and integrate these traditional healing practices into mainstream healthcare and economy. The Ministry's mandate includes education, research, and propagation of Ayush systems both domestically and internationally. AYUSHEXCIL, formed under the Ministry of Ayush, plays a crucial role in facilitating the export of Ayush products and services, ensuring they meet international standards and gain global recognition. The MoU between AYUSHEXCIL and Zepto aims to bridge the gap between Ayush manufacturers, especially small and medium enterprises (SMEs), and urban consumers. By partnering with Zepto, a quick-commerce platform known for its rapid delivery network, Ayush products can achieve significantly enhanced last-mile accessibility. Crucially, the agreement also focuses on quality assurance, which is paramount for building consumer trust and ensuring the credibility of traditional medicines. This means that products listed through this partnership are expected to adhere to specific quality benchmarks, likely aligned with regulatory standards set by the Ministry of Ayush. **Key Stakeholders Involved:** 1. **AYUSHEXCIL (Ayush Export Promotion Council):** As the primary facilitator, AYUSHEXCIL is responsible for promoting Ayush exports, ensuring product quality, and connecting manufacturers with market opportunities. Its role in this MoU is to onboard verified Ayush brands and ensure adherence to quality standards. 2. **Zepto:** This e-commerce platform provides the technological infrastructure and logistics network for rapid delivery, making Ayush products readily available to a wider customer base. Its innovation-driven model is key to improving last-mile access. 3. **Ministry of Ayush:** The apex body that formulates policies, regulates, and promotes Ayush systems. The Minister's statement highlights the government's strategic vision behind such partnerships. 4. **Ayush Product Manufacturers and SMEs:** These are the producers of traditional medicines and wellness products who will gain direct access to a large consumer base through Zepto, potentially boosting their sales and market reach. 5. **Consumers:** The ultimate beneficiaries, who will enjoy improved access to trusted, quality-assured Ayush products, contributing to their health and wellness. **Significance for India:** This collaboration holds immense significance for India across multiple dimensions. Economically, it is a major boost for the domestic Ayush industry, which is projected to grow substantially. By expanding market access, it supports 'Make in India' and 'Vocal for Local' initiatives, empowering local manufacturers and potentially creating jobs. It aligns with the 'Startup India' initiative by integrating an innovative startup (Zepto) into a traditional sector. Socially, it democratizes access to traditional healthcare, making wellness products more accessible to urban populations, thereby contributing to public health, an objective enshrined broadly under Directive Principles of State Policy, particularly **Article 47**, which mandates the State to improve public health. For quality assurance, the partnership leverages existing frameworks under the **Drugs and Cosmetics Act, 1940** (which includes specific provisions for Ayurvedic, Siddha and Unani drugs) and the **Consumer Protection Act, 2019**, ensuring consumer safety and trust. **Historical Context and Future Implications:** The journey of Ayush systems in independent India has seen a gradual resurgence. Post-independence, while allopathy received significant state patronage, traditional systems struggled to find their place. However, recent decades, especially since the early 2000s, have witnessed a renewed focus, culminating in the creation of the Ministry of Ayush. This push gained international recognition with the establishment of the **WHO Global Centre for Traditional Medicine (GCTM) in Jamnagar, Gujarat**, in 2022, underscoring India's leadership in the global traditional medicine landscape. This MoU is a logical extension of this broader strategy to mainstream Ayush. Looking ahead, this partnership could serve as a blueprint for similar collaborations with other e-commerce and quick-commerce platforms, further expanding the reach of Ayush products. It is likely to spur greater innovation in product development, packaging, and marketing within the Ayush sector. The emphasis on quality assurance could lead to more stringent regulatory mechanisms and better compliance from manufacturers, enhancing the overall reputation and trustworthiness of Indian traditional medicine globally. This move also contributes to India's 'Digital India' vision by integrating traditional sectors with digital platforms, ensuring that the benefits of technological advancements reach all facets of the economy and society. This strategic partnership is not just about selling products; it's about building an ecosystem where traditional Indian knowledge meets modern efficiency, ensuring quality, accessibility, and ultimately, a healthier population.